HEALIANCE
DEAD

Serial Number

85133892

Owner

DIGEN PHARMACEUTICALS, GmbH

Attorney

Arturo Pérez-Guerrero

Filing Date

Sep 20, 2010

Add to watchlist:

No watchlists yet
View on USPTO

HEALIANCE Trademark

Serial Number: 85133892 • Registration: 4156435

HEALIANCE is a trademark filed by DIGEN PHARMACEUTICALS, GmbH on September 20, 2010. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

DIGEN PHARMACEUTICALS, GmbH

Rudolfsplatz 3/9
1010 Wien , AT

Entity Type: 03

Trademark Details

Filing Date

September 20, 2010

Registration Date

June 12, 2012

Published for Opposition

March 27, 2012

Cancellation Date

January 18, 2019

Goods & Services

Pharmaceuticals preparations, namely, biological and biosimilar preparations for use in the treatment and prevention of diabetes caused ulcers, skin ulcers, peptic ulcers, stomach ulcers, foot ulcers, ischemic ulcers, venous ulcers, varicose ulcers and vascular ulcers; pharmaceutical preparations for use in the treatment of cancer; nutraceuticals; prenatal vitamins; antibacterial preparations; antifungal preparations; antivirals; anthelmintics; antiprotozoal agents; pharmaceutical preparations for the treatment of ulcers and gastro-intestinal disorders; prescription medicines, namely, prokinetics for enhancing gastrointestinal motility; emetic preparations; emetics; analgesics; anti-inflammatories; antihistamines; pharmaceutical preparations and medicines for treatment of hypertension and for lowering lipid levels, namely, vasodilators, vaso-constrictors, vascular sedatives; diuretics; pharmaceutical preparations and medicines for calcium metabolism regulation; pharmaceutical medicines for inhibiting prostatic hypertrophy; antidepressants

Chemical additives for use in the manufacture of pharmaceuticals and medicines; active chemical ingredients for use in the manufacture of pharmaceuticals for treating and preventing diabetes caused ulcers, skin ulcers, peptic ulcers, stomach ulcers, foot ulcers, ischemic ulcers, venous ulcers, varicose ulcers and vascular ulcers; Diagnostic preparations for clinical or medical laboratory use; Diagnostic reagents for clinical or medical laboratory use; Reagents for scientific or medical research use

Research in the field of chemistry; biological research; pharmaceutical research services

Filing History

CANCELLED SEC. 8 (6-YR)
Jan 18, 2019 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 12, 2017 REM1
REGISTERED-PRINCIPAL REGISTER
Jun 12, 2012 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 27, 2012 NPUB
PUBLISHED FOR OPPOSITION
Mar 27, 2012 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 7, 2012 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 17, 2012 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 14, 2012 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 30, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 30, 2012 CRFA
ASSIGNED TO LIE
Jan 24, 2012 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 22, 2012 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 7, 2011 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 7, 2011 GNSL
SUSPENSION LETTER WRITTEN
Sep 7, 2011 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 21, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 21, 2011 CRFA
ASSIGNED TO LIE
Jul 18, 2011 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 5, 2011 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 4, 2011 GNRN
NON-FINAL ACTION E-MAILED
Jan 4, 2011 GNRT
NON-FINAL ACTION WRITTEN
Jan 4, 2011 CNRT
ASSIGNED TO EXAMINER
Dec 27, 2010 DOCK
NOTICE OF PSEUDO MARK MAILED
Sep 24, 2010 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 23, 2010 NWOS
NEW APPLICATION ENTERED
Sep 23, 2010 NWAP